Información del artículo
El Texto completo está disponible en PDF
REFERENCES
[1.]
S.C. Sim, R.B. Altman, M. Ingelman-Sundberg.
Databases in the area of pharmacogenetics.
Hum Mutat., 32 (2011), pp. 526-531
[2.]
W.S. Oetting.
Clinical genetics & human genome variation: the 2008 Human Genome Variation Society scientific meeting.
Hum Mutat., 30 (2009), pp. 852-856
[3.]
N. Pinto, M.E. Dolan.
Clinically relevant genetic variations in drug metabolizing enzymes.
Curr Drug Metab., 12 (2011), pp. 487-497
[4.]
P.M. Boone, W. Wiszniewski, J.R. Lupski.
Genomic medicine and neurological disease.
Hum Genet, (2011),
[5.]
I. Johansson, M. Ingelman-Sundberg.
Genetic polymorphism and toxicology-with emphasis on cytochrome p450.
Toxicol Sci., 120 (2011), pp. 1-13
[6.]
R. Searle, P.M. Hopkins.
Pharmacogenomic variability and anaesthesia.
Br J Anaesth., 103 (2009), pp. 14-25
[7.]
J.G. Restrepo, E. García-Martín, C. Martínez.
Polymorphic drug metabolism in anaesthesia.
Curr Drug Metab., 10 (2009), pp. 236-246
[8.]
J.F. Carlquist, J.L. Anderson.
Pharmacogenetic mechanisms underlying unanticipated drug responses.
Discov Med., 11 (2011), pp. 469-478
[9.]
A. Gómez, M. Ingelman-Sundberg.
Pharmacoepigenetics: its role in interindividual differences in drug response.
Clin Pharmacol Ther., 85 (2009), pp. 426-430
[10.]
W. Baer-Dubowska, A. Majchrzak-Celinska, M. Cichocki.
Pharmocoepigenetics: a new approach to predicting individual drug responses and targeting new drugs.
Pharmacol Rep., 63 (2011), pp. 293-304
[11.]
J.I. Martín-Subero, M. Esteller.
Profiling epigenetic alterations in disease.
Adv Exp Med Biol., 711 (2011), pp. 162-177
[12.]
R. Searle, P.M. Hopkins.
Pharmacogenomic variability and anaesthesia.
Br J Anaesth., 103 (2009), pp. 14-25
Copyright © 2011. Revista Colombiana de Anestesiología
Opciones de artículo